UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study.

Price DB, Scadding G, Bachert C, Saleh H, Nasser S, Carter V, Ziegenweidt JV, Durieux AMS, Ryan D

NPJ Prim Care Respir Med 2016.

By |September 13th, 2016|OPCRD|0 Comments

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease

Lipworth B, Skinner D, Devereux G, Thomas V, Ling JZJ, Martin J, Carter V, Price DB

Heart 2016.

By |September 13th, 2016|OPCRD|0 Comments

Long-acting β-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

Turner S, Richardson K, Murray C, Thomas M, Hillyer EV, Burden A, Price DB; Respiratory Effectiveness Group

J Allergy Clin Immunol Pract 2016.

By |September 13th, 2016|OPCRD|0 Comments

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K
Int J Chron Obstruct Pulmon Dis 2014; 9: 889-904.

By |August 27th, 2014|OPCRD|0 Comments

Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients

Price D, Thomas V, von Ziegenweidt J, Gould S, Hutton C, King C

J Asthma Allergy 2014; 10(7): 31-51.

By |April 10th, 2014|OPCRD|0 Comments

Current evidence and future research needs for FeNO measurement in respiratory diseases

Bjermer L, Alving, K, Diamant Z, Magnussen H, Pavord I, Piacentini G, Price D, Roche N, Sastre J, Thomas M, Usmani O

Respir Med 2014; 108(6): 830-41.

By |February 17th, 2014|OPCRD|0 Comments

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort

Jones R, Price D, Ryan D, Sims E, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin D, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman E

Lancet Respir Med 2014; 2(4): 267-76.

By |February 12th, 2014|OPCRD|0 Comments

Integrating evidence for managing asthma in patients who smoke

Price D, Bjermer L, Popov T, Chisholm A

Allergy Asthma Immunol Res 2014; 6(2): 114–20.

By |February 7th, 2014|OPCRD|0 Comments

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care

Price D, Ryan D, Burden A, Von Ziegenweidt J, Gould S, Freeman D, Gruffydd-Jones K, Copland A, Godley C, Chisholm A, Thomas M

Clin Transl Allergy 2013; 3(1): 37.

By |November 7th, 2013|OPCRD, Uncategorized|0 Comments

Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients

Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A, Brockman J, King C, Papi A

Prim Care Respir J 2013; 22(4): 439-48.

By |November 2nd, 2013|OPCRD|0 Comments